#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastroenteropancreatic neuroendocrine tumour disease Pulmonary arterial hypertension Amyotrophic lateral sclerosis gene carrier Toxic epidermal necrolysis B-cell type acute leukaemia Erythema Follicle centre lymphoma follicular grade I II – III refractory Narcolepsy Waldenstrom's macroglobulinaemia recurrent Angiosarcoma metastatic Oesophageal squamous cell carcinoma stage III B-cell small lymphocytic lymphoma Transferrin decreased Ovarian cancer stage IV Chronic lymphocytic leukaemia recurrent More trials…

    Learn about Rare Diseases

    Fragile X syndrome – Diagnostics Hepatic angiosarcoma Indolent systemic mastocytosis – Trials in Disease Glycogen storage disease type I – Basic Information Hypereosinophilic syndrome – Treatment Mucopolysaccharidosis – Life with Disease Ehlers-Danlos syndrome – Trials in Disease Biotinidase deficiency – Life with Disease Shprintzen-Goldberg syndrome – Trials in Disease Medulloblastoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    RNK001 Amphotericine B, Liposome Upacicalcet Sodium Hydrate Buprenorphine Sodium Chloride Ph. Eur. Human Serum Albumin Ht-29-A IHMA-2121908-1 Enlicitide Chloride MB-HUCART19.1 Haemophilus Influenzae Ribitol Epacadostat Lactic Acid Mk-1084 HTL0022537 Adrenaline Tartrate Ph. Eur. Isatuximab Corline Heparin Conjugate Riliprubart More therapies…

    Learn about Your Condition

    Genital herpes simplex Naevoid melanoma Ligament operation Breast cancer in situ Prader-Willi syndrome Renal injury Vasoplegia syndrome Dupuytren's contracture Wiskott-Aldrich syndrome Somatic symptom disorder Infantile spasms Anal abscess Eructation Compulsive sexual behaviour Eyelid ptosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of apremilast‑induced headache and migraine in women with migraine without aura

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Migraine without aura
    Investigated Drugs:
    • Apremilast
    Denmark

  • Durvalumab personalized consolidation immunotherapy after chemoradiotherapy in patients with stage III non‑small cell lung cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Durvalumab
    France

  • Safety and Tolerability of Intrathecal ION337 in Patients with Dravet Syndrome

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Severe myoclonic epilepsy of infancy
    Belgium France Germany Portugal Spain

  • Study of hu14.18K322A with temozolomide and irinotecan in children and adolescents with high‑risk neuroblastoma

    Not yet recruiting

    4 1 1 1
    Investigated Drugs:
    • Irinotecan
    • Temozolomide
    Denmark France Germany Ireland Spain

  • Micronised progesterone luteal-phase support improves live birth rates in women with unexplained infertility

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Infertility
    • Infertility female
    Investigated Drugs:
    • Progesterone, Micronised
    The Netherlands

  • Dalbavancin versus standard drug combination for treatment of infective endocarditis caused by Gram‑positive cocci in adult patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocarditis bacterial
    Investigated Drugs:
    • Ampicillin
    • Cefaclor
    • Cefalexin
    Germany
Previous Page
1 … 685 686 687 688 689 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!